Biophytis (EPA:ALBPS) | Finanzwire

Basculer en Français

10363	Companies
215737	Keywords
145504	Articles
114259	Press releases

Home
Companies
Biophytis

REGULATED PRESS RELEASE

published on 12/24/2024 at 07:00, 1 year 4 months ago

Biophytis Will Be In San Franscico During The 2025 JP Morgan Healthcare Conference
Biophytis to attend 2025 JP Morgan Healthcare Conference in San Francisco and participate in Sachs Conference and BIO@JPM Week. The company focuses on developing treatments for age-related diseases

Biophytis Biotechnology Age-related Diseases San Francisco JP Morgan Healthcare Conference
BRIEF

published on 12/23/2024 at 07:05, 1 year 4 months ago

Biophytis Presents Obesity Program at SCWD Congress

Biophytis BIO101 Obesity GLP-1 RAs Quinolia Study
REGULATED PRESS RELEASE

published on 12/23/2024 at 07:00, 1 year 4 months ago

Biophytis showcased the OBA program in obesity at the 17th SCWD international congress
Biophytis presented the OBA program in obesity at the 17th SCWD congress, showcasing positive results of BIO101 in overweight and obese patients, supporting further clinical development

Biophytis Clinical Development BIO101 Obesity OBA Program
BRIEF

published on 12/02/2024 at 07:05, 1 year 5 months ago

Biophytis Engages in SCWD Congress and Hosts Obesity Investor Call

Biophytis Investor Call Obesity Treatment GLP-1 RA SCWD Congress
REGULATED PRESS RELEASE

published on 12/02/2024 at 07:00, 1 year 5 months ago

Biophytis participates in the 17th SCWD Congress and hosts an Obesity Investor Call
Biophytis announces participation in the 17th SCWD Congress and hosting an Obesity Investor Call. Key opinion leaders to discuss GLP-1 RA therapy. Event on December 6, 2024

Biophytis Clinical Research Obesity Investor Call SCWD Congress GLP-1 RA Therapy
BRIEF

published on 09/30/2024 at 23:05, 1 year 7 months ago

Biophytis Reports First-Half Financial Results and Updates on Business Activities

Financial Results Biophytis Clinical Trials Obesity Treatment Partnerships
PRESS RELEASE

published on 09/30/2024 at 23:00, 1 year 7 months ago

Biophytis Publishes First-Half Financial Results and Provides an Update on its Business Activities
Biophytis publishes first-half financial results and business activities update, including launch of obesity program and licensing agreement with Blanver for Latin America, with a focus on key achievements and financial highlights

Financial Results Biophytis Licensing Agreement Business Activities Obesity Program
REGULATED PRESS RELEASE

published on 09/30/2024 at 23:00, 1 year 7 months ago

Biophytis Publishes First-Half Financial Results and Provides an Update on its Business Activities
Biophytis publishes first-half financial results and updates on business activities, highlighting key achievements including launch of OBA program for obesity with BIO101 and exclusive licensing agreement with Blanver for Latin America

Financial Results Biophytis Latin America BIO101 OBA Program
BRIEF

published on 07/22/2024 at 08:17, 1 year 9 months ago

Biophytis Enters Asia Market with Strategic Partnerships

Biophytis Pharmaceutical Partnerships Market Expansion Asia
PRESS RELEASE

published on 07/22/2024 at 08:12, 1 year 9 months ago

Biophytis deploys its partnership strategy and signs two contracts with local agents in Asia
Biophytis signs partnership contracts with local agents in Asia to accelerate deployment of BIO101 drug candidate, targeting age-related diseases in key markets like Japan and China

Biophytis Partnership Asia Age-related Diseases BIO101

Accesswire

Published on 05/07/2026 at 11:00, 33 minutes ago

Kingfisher Metals Announces Fully Funded 2026 Exploration Program
Published on 05/07/2026 at 09:05, 2 hours 28 minutes ago

Nano One Appoints Jason Zandberg as Director of Capital Markets
Published on 05/07/2026 at 05:40, 5 hours 53 minutes ago

New Horizon Aircraft Ltd. Announces Pricing of $20 Million Offering of Common Shares
Published on 05/07/2026 at 02:00, 9 hours 33 minutes ago

Lobe Sciences Ltd. Announces Participation in the D. Boral Capital Global Conference in New York
Published on 05/06/2026 at 23:30, 12 hours 3 minutes ago

Stabilis Solutions Announces First Quarter 2026 Results

View all ACCESSWIRE

EQS Group

Published on 05/07/2026 at 11:15, 17 minutes ago

LUYUAN Opens European R&D and Innovation Center in Munich, Anchoring Localization with "China R&D + German Engineering"
Published on 05/07/2026 at 11:00, 32 minutes ago

Pylontech Recognized as BloombergNEF Tier 1 Energy Storage Manufacturer
Published on 05/07/2026 at 11:00, 33 minutes ago

ABB Ltd: ABB share buybacks - April 30, 2026 - May 6, 2026
Published on 05/07/2026 at 10:45, 48 minutes ago

REPLOID secures growth financing in the double-digit million-euro range from Raiffeisen Bank International
Published on 05/07/2026 at 10:35, 57 minutes ago

Encouraging New Data: Grafalon Benefits High-Risk Pediatric HSCT Patients in the FORUM Study

Les Echos

Published on 05/07/2026 at 07:43, 3 hours 49 minutes ago

ENGIE - Q1 2026 financial information
Published on 05/06/2026 at 18:00, 17 hours 32 minutes ago

Access to information in respect of the General Shareholders’ Meeting to be held on June 4, 2026
Published on 05/06/2026 at 18:00, 17 hours 33 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of April 30, 2026
Published on 05/06/2026 at 17:45, 17 hours 48 minutes ago

Information concerning the total number of voting rights and shares 2026 04 30
Published on 05/06/2026 at 17:45, 17 hours 48 minutes ago

Declaration of voting rights at the end of April 2026

View all LES ECHOS COMFI WIRE